{"events":[{"id":197,"event_type":"analysis_completed","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755","gap_id":"gap-pubmed-20260406-062118-e3613755","question":"What molecular mechanisms mediate SPP1-induced microglial phagocytic activation and synaptic targeting?","domain":"neuroinflammation","num_rounds":5},"consumed_by":["market_dynamics"],"created_at":"2026-04-15 23:30:54"},{"id":196,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755","analysis_id":"SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755","question":"What molecular mechanisms mediate SPP1-induced microglial phagocytic activation and synaptic targeting?","num_rounds":5,"quality_score":0.55,"num_hypotheses_generated":7,"num_hypotheses_surviving":3,"personas_used":["theorist","skeptic","domain_expert","synthesizer","computational_biologist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-15 23:30:54"},{"id":195,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755","gap_id":"gap-pubmed-20260406-062118-e3613755","question":"What molecular mechanisms mediate SPP1-induced microglial phagocytic activation and synaptic targeting?","domain":"neuroinflammation"},"consumed_by":[],"created_at":"2026-04-15 23:27:57"},{"id":189,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-04-gap-20260404-microglial-priming-early-ad","gap_id":"gap-20260404-microglial-priming-early-ad","question":"Neuroinflammation and microglial priming in early Alzheimer's Disease","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 13:52:07"},{"id":188,"event_type":"analysis_completed","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-12-gap-debate-20260410-112908-13c403ee","gap_id":"gap-debate-20260410-112908-13c403ee","question":"What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?","domain":"neuropharmacology","num_rounds":6},"consumed_by":["market_dynamics"],"created_at":"2026-04-12 13:37:01"},{"id":187,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-12-gap-debate-20260410-112908-13c403ee","analysis_id":"SDA-2026-04-12-gap-debate-20260410-112908-13c403ee","question":"What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?","num_rounds":6,"quality_score":0.55,"num_hypotheses_generated":7,"num_hypotheses_surviving":3,"personas_used":["theorist","skeptic","domain_expert","synthesizer","medicinal_chemist","clinical_trialist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-12 13:37:01"},{"id":186,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-12-gap-debate-20260410-112908-13c403ee","gap_id":"gap-debate-20260410-112908-13c403ee","question":"What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?","domain":"neuropharmacology"},"consumed_by":[],"created_at":"2026-04-12 13:32:57"},{"id":185,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-04-gap-20260404-microglial-priming-early-ad","gap_id":"gap-20260404-microglial-priming-early-ad","question":"Neuroinflammation and microglial priming in early Alzheimer's Disease","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 13:27:15"},{"id":184,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-12-gap-debate-20260410-112902-5b3fc173","gap_id":"gap-debate-20260410-112902-5b3fc173","question":"Are age-related DNA methylation changes protective adaptations or pathological drivers in neurodegeneration?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 13:22:14"},{"id":183,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:49:57"},{"id":182,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:43:15"},{"id":181,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:35:39"},{"id":180,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:29:21"},{"id":179,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:21:25"},{"id":178,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:11:31"},{"id":177,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"sda-2026-04-01-gap-006","gap_id":"gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-12 11:03:22"},{"id":174,"event_type":"hypothesis_scored","source":"test_agent","payload":{"test":"data"},"consumed_by":["market_dynamics"],"created_at":"2026-04-12 02:53:30"},{"id":173,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-11-gap-debate-20260410-111558-f9487fea","gap_id":"gap-debate-20260410-111558-f9487fea","question":"Does reduced Prevotellaceae abundance cause PD pathology or result from it?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 17:36:54"},{"id":172,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-11-gap-debate-20260410-111558-f9487fea","gap_id":"gap-debate-20260410-111558-f9487fea","question":"Does reduced Prevotellaceae abundance cause PD pathology or result from it?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 17:23:06"},{"id":171,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-11-gap-debate-20260410-111542-7f40fe3e","gap_id":"gap-debate-20260410-111542-7f40fe3e","question":"Are DNA methylation changes in neurodegeneration causal drivers or protective consequences of aging?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 17:16:47"},{"id":170,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-01-gap-lipid-rafts-2026-04-01","gap_id":"SDA-2026-04-01-gap-lipid-rafts-2026-04-01","question":"Lipid raft composition changes in synaptic neurodegeneration","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 16:39:06"},{"id":169,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-11-sda-2026-04-01-gap-006","analysis_id":"SDA-2026-04-11-sda-2026-04-01-gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","num_rounds":4,"quality_score":0.63,"num_hypotheses_generated":7,"num_hypotheses_surviving":2,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-11 08:11:40"},{"id":168,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-11-sda-2026-04-01-gap-006","gap_id":"sda-2026-04-01-gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 08:09:38"},{"id":167,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-11-sda-2026-04-01-gap-006","gap_id":"sda-2026-04-01-gap-006","question":"TDP-43 phase separation therapeutics for ALS-FTD","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-11 08:06:46"},{"id":166,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-01-gap-lipid-rafts-2026-04-01","gap_id":"SDA-2026-04-01-gap-lipid-rafts-2026-04-01","question":"Lipid raft composition changes in synaptic neurodegeneration","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 21:37:45"},{"id":165,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-04-gap-epigenetic-reprog-b685190e","analysis_id":"SDA-2026-04-04-gap-epigenetic-reprog-b685190e","question":"Epigenetic reprogramming in aging neurons","num_rounds":4,"quality_score":0.55,"num_hypotheses_generated":7,"num_hypotheses_surviving":3,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 16:16:09"},{"id":164,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-04-gap-epigenetic-reprog-b685190e","gap_id":"SDA-2026-04-04-gap-epigenetic-reprog-b685190e","question":"Epigenetic reprogramming in aging neurons","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 16:13:56"},{"id":163,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","analysis_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","question":"The abstract identifies tissue-specific networks that may underlie Mendelian disease phenotypes but doesn't explain the mechanistic basis for why the same genetic variant causes different phenotypes a","num_rounds":6,"quality_score":0.5,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer","computational_biologist","epidemiologist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 14:46:04"},{"id":162,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","question":"The abstract identifies tissue-specific networks that may underlie Mendelian disease phenotypes but doesn't explain the mechanistic basis for why the same genetic variant causes different phenotypes across tissues. Understanding these mechanisms is crucial for developing tissue-targeted therapies for neurogenetic disorders.\n\nGap type: unexplained_observation\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:41:49"},{"id":161,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-b5f44522","question":"The abstract identifies tissue-specific networks that may underlie Mendelian disease phenotypes but doesn't explain the mechanistic basis for why the same genetic variant causes different phenotypes across tissues. Understanding these mechanisms is crucial for developing tissue-targeted therapies for neurogenetic disorders.\n\nGap type: unexplained_observation\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:39:58"},{"id":160,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","analysis_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","question":"While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principles governing how interaction networks specify subcellular function remain unclear. This knowl","num_rounds":7,"quality_score":0.5,"num_hypotheses_generated":7,"num_hypotheses_surviving":1,"personas_used":["theorist","skeptic","domain_expert","synthesizer","computational_biologist","clinical_trialist","medicinal_chemist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 14:39:58"},{"id":159,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","question":"While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principles governing how interaction networks specify subcellular function remain unclear. This knowledge gap limits our ability to predict how disease mutations disrupt cellular compartmentalization in neurons.\n\nGap type: open_question\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)","domain":"synaptic biology"},"consumed_by":[],"created_at":"2026-04-10 14:35:22"},{"id":158,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47","question":"While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principles governing how interaction networks specify subcellular function remain unclear. This knowledge gap limits our ability to predict how disease mutations disrupt cellular compartmentalization in neurons.\n\nGap type: open_question\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)","domain":"synaptic biology"},"consumed_by":[],"created_at":"2026-04-10 14:33:26"},{"id":157,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","analysis_id":"SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","question":"The abstract shows that dilncRNAs drive molecular crowding of DDR proteins into phase-separated condensates, but the specific molecular mechanisms by which these RNAs induce this biophysical transitio","num_rounds":7,"quality_score":0.56,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer","clinical_trialist","epidemiologist","computational_biologist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 14:33:26"},{"id":156,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","question":"The abstract shows that dilncRNAs drive molecular crowding of DDR proteins into phase-separated condensates, but the specific molecular mechanisms by which these RNAs induce this biophysical transition are not explained. Understanding this mechanism is crucial since aberrant RNA-protein condensates are implicated in neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors. (2020, Nature cell biology, PMID:31570834)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:29:06"},{"id":155,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","question":"What determines organelle-specific autophagy selectivity in neurodegenerative disease contexts?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:17:40"},{"id":154,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","question":"What determines organelle-specific autophagy selectivity in neurodegenerative disease contexts?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:10:58"},{"id":153,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","analysis_id":"SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","question":"How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds?","num_rounds":4,"quality_score":0.55,"num_hypotheses_generated":7,"num_hypotheses_surviving":3,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 14:10:49"},{"id":152,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","question":"How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:08:47"},{"id":151,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca","question":"The abstract shows that dilncRNAs drive molecular crowding of DDR proteins into phase-separated condensates, but the specific molecular mechanisms by which these RNAs induce this biophysical transition are not explained. Understanding this mechanism is crucial since aberrant RNA-protein condensates are implicated in neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors. (2020, Nature cell biology, PMID:31570834)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 14:00:35"},{"id":150,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95","analysis_id":"SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95","question":"While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's unclear what molecular features determine which DDR proteins are selectively recruited versus excluded from these conde","num_rounds":7,"quality_score":0.51,"num_hypotheses_generated":7,"num_hypotheses_surviving":1,"personas_used":["theorist","skeptic","domain_expert","synthesizer","clinical_trialist","epidemiologist","computational_biologist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 14:00:35"},{"id":149,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95","question":"While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's unclear what molecular features determine which DDR proteins are selectively recruited versus excluded from these condensates. This selectivity mechanism could be relevant to protein aggregation diseases where specific proteins aberrantly phase separate.\n\nGap type: unexplained_observation\nSource paper: Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors. (2020, Nature cell biology, PMID:31570834)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:56:49"},{"id":148,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_gut-brain-ad","analysis_id":"gut-brain-ad","question":"Gut-Brain Axis Therapeutics for Alzheimer's Disease?","num_rounds":4,"quality_score":0.61,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 13:56:28"},{"id":147,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gut-brain-ad","gap_id":"gut-brain-ad","question":"Gut-Brain Axis Therapeutics for Alzheimer's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:54:35"},{"id":146,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gut-brain-ad","gap_id":"gut-brain-ad","question":"Gut-Brain Axis Therapeutics for Alzheimer's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:51:34"},{"id":145,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gut-brain-ad","gap_id":"gut-brain-ad","question":"Gut-Brain Axis Therapeutics for Alzheimer's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:45:57"},{"id":144,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_sda-2026-04-01-gap-004","analysis_id":"sda-2026-04-01-gap-004","question":"Why do entorhinal cortex layer II stellate neurons die first in AD? Their unique electrophysiological properties, grid cell function, and high metabolic demand may contribute, but the molecular basis ","num_rounds":6,"quality_score":0.6,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer","clinical_trialist","medicinal_chemist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 13:45:57"},{"id":143,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-004","gap_id":"sda-2026-04-01-gap-004","question":"Why do entorhinal cortex layer II stellate neurons die first in AD? Their unique electrophysiological properties, grid cell function, and high metabolic demand may contribute, but the molecular basis of selective vulnerability is unknown.","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:42:11"},{"id":142,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-004","gap_id":"sda-2026-04-01-gap-004","question":"Why do entorhinal cortex layer II stellate neurons die first in AD? Their unique electrophysiological properties, grid cell function, and high metabolic demand may contribute, but the molecular basis of selective vulnerability is unknown.","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:38:45"},{"id":141,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_sda-2026-04-01-gap-005","analysis_id":"sda-2026-04-01-gap-005","question":"PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns (tufted astrocytes vs astrocytic plaques). Whether tau strains or regional cellular environments drive these differences","num_rounds":7,"quality_score":0.39,"num_hypotheses_generated":7,"num_hypotheses_surviving":2,"personas_used":["theorist","skeptic","domain_expert","synthesizer","epidemiologist","computational_biologist","clinical_trialist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 13:38:45"},{"id":140,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-005","gap_id":"sda-2026-04-01-gap-005","question":"PSP and CBD both involve 4R-tau but produce distinct neuropathological patterns (tufted astrocytes vs astrocytic plaques). Whether tau strains or regional cellular environments drive these differences is unresolved.","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:35:07"},{"id":139,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_sda-2026-04-01-gap-006","analysis_id":"sda-2026-04-01-gap-006","question":"TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small molecules targeting phase separation properties could be therapeutic but the design principles are undefined.","num_rounds":6,"quality_score":0.2,"num_hypotheses_generated":4,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer","medicinal_chemist","clinical_trialist"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 13:34:58"},{"id":138,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-006","gap_id":"sda-2026-04-01-gap-006","question":"TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small molecules targeting phase separation properties could be therapeutic but the design principles are undefined.","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 13:31:26"},{"id":137,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","question":"How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis?","num_rounds":4,"quality_score":0.575,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:43:46"},{"id":136,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","question":"How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:41:41"},{"id":135,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","question":"Can circadian interventions reverse microglial priming independent of sleep disruption effects?","num_rounds":4,"quality_score":0.49,"num_hypotheses_generated":7,"num_hypotheses_surviving":5,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:41:41"},{"id":134,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","gap_id":"SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","question":"Can circadian interventions reverse microglial priming independent of sleep disruption effects?","domain":"chronobiology"},"consumed_by":[],"created_at":"2026-04-10 12:39:53"},{"id":133,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","question":"Do different priming stimuli require distinct therapeutic approaches or share common epigenetic pathways?","num_rounds":4,"quality_score":0.66,"num_hypotheses_generated":7,"num_hypotheses_surviving":5,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:39:53"},{"id":132,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","gap_id":"SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","question":"Do different priming stimuli require distinct therapeutic approaches or share common epigenetic pathways?","domain":"immunology"},"consumed_by":[],"created_at":"2026-04-10 12:37:39"},{"id":131,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","question":"What are the minimal structural requirements for HSP70/HSP90 inhibitors to achieve tau-selectivity over essential cellular functions?","num_rounds":4,"quality_score":0.54,"num_hypotheses_generated":7,"num_hypotheses_surviving":2,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:37:39"},{"id":130,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","question":"What are the minimal structural requirements for HSP70/HSP90 inhibitors to achieve tau-selectivity over essential cellular functions?","domain":"drug discovery"},"consumed_by":[],"created_at":"2026-04-10 12:34:59"},{"id":129,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-d279750b","analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-d279750b","question":"Do tau-containing vesicles exhibit unique surface glycosylation patterns that distinguish them from normal vesicles?","num_rounds":4,"quality_score":0.54,"num_hypotheses_generated":7,"num_hypotheses_surviving":0,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:34:59"},{"id":128,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-d279750b","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-d279750b","question":"Do tau-containing vesicles exhibit unique surface glycosylation patterns that distinguish them from normal vesicles?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:33:21"},{"id":127,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","question":"Which specific post-translational modifications on pathological tau create druggable epitopes absent in physiological tau?","num_rounds":4,"quality_score":0.15,"num_hypotheses_generated":0,"num_hypotheses_surviving":0,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:33:21"},{"id":126,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","question":"Which specific post-translational modifications on pathological tau create druggable epitopes absent in physiological tau?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:32:43"},{"id":125,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","question":"Can nanobodies achieve selective membrane penetration into tau-containing vesicles without affecting normal cellular vesicles?","num_rounds":4,"quality_score":0.5,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:32:43"},{"id":124,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","question":"Can nanobodies achieve selective membrane penetration into tau-containing vesicles without affecting normal cellular vesicles?","domain":"molecular biology"},"consumed_by":[],"created_at":"2026-04-10 12:28:29"},{"id":123,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-trem2-ad","analysis_id":"SDA-2026-04-10-trem2-ad","question":"TREM2 Therapeutic Strategy Post-INVOKE-2?","num_rounds":4,"quality_score":0.5,"num_hypotheses_generated":7,"num_hypotheses_surviving":2,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:27:21"},{"id":122,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-trem2-ad","gap_id":"trem2-ad","question":"TREM2 Therapeutic Strategy Post-INVOKE-2?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:25:19"},{"id":121,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-sda-2026-04-01-gap-007","analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-007","question":"Astrocyte reactivity subtypes in neurodegeneration","num_rounds":4,"quality_score":0.71,"num_hypotheses_generated":7,"num_hypotheses_surviving":3,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:25:19"},{"id":120,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-007","gap_id":"sda-2026-04-01-gap-007","question":"Astrocyte reactivity subtypes in neurodegeneration","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:22:53"},{"id":119,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-10-gba-pd","analysis_id":"SDA-2026-04-10-gba-pd","question":"GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?","num_rounds":4,"quality_score":0.6,"num_hypotheses_generated":7,"num_hypotheses_surviving":4,"personas_used":["theorist","skeptic","domain_expert","synthesizer"]},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 12:22:53"},{"id":118,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gba-pd","gap_id":"gba-pd","question":"GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:20:39"},{"id":117,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-trem2-ad","gap_id":"trem2-ad","question":"TREM2 Therapeutic Strategy Post-INVOKE-2?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:16:28"},{"id":116,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-sda-2026-04-01-gap-007","gap_id":"sda-2026-04-01-gap-007","question":"Astrocyte reactivity subtypes in neurodegeneration","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:14:08"},{"id":115,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gba-pd","gap_id":"gba-pd","question":"GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 12:11:28"},{"id":114,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062111-e3e328bf","question":"What are the specific pathophysiological mechanisms underlying uncommon immune-mediated myelopathies?","domain":"neuroinflammation"},"consumed_by":[],"created_at":"2026-04-10 12:00:58"},{"id":113,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062132-5d93ddb2","question":"What determines organelle-specific autophagy selectivity in neurodegenerative disease contexts?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:59:21"},{"id":112,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3","question":"How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:58:31"},{"id":111,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","question":"How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:56:45"},{"id":110,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","gap_id":"SDA-2026-04-08-gap-debate-20260406-062033-16eccec1","question":"Can circadian interventions reverse microglial priming independent of sleep disruption effects?","domain":"chronobiology"},"consumed_by":[],"created_at":"2026-04-10 11:54:57"},{"id":109,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","gap_id":"SDA-2026-04-08-gap-debate-20260406-062039-f02efa4b","question":"Do different priming stimuli require distinct therapeutic approaches or share common epigenetic pathways?","domain":"immunology"},"consumed_by":[],"created_at":"2026-04-10 11:53:03"},{"id":108,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-5407d57d","question":"What are the minimal structural requirements for HSP70/HSP90 inhibitors to achieve tau-selectivity over essential cellular functions?","domain":"drug discovery"},"consumed_by":[],"created_at":"2026-04-10 11:50:49"},{"id":107,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-d279750b","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-d279750b","question":"Do tau-containing vesicles exhibit unique surface glycosylation patterns that distinguish them from normal vesicles?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:50:17"},{"id":106,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd","question":"Which specific post-translational modifications on pathological tau create druggable epitopes absent in physiological tau?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:49:07"},{"id":105,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","gap_id":"SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1","question":"Can nanobodies achieve selective membrane penetration into tau-containing vesicles without affecting normal cellular vesicles?","domain":"molecular biology"},"consumed_by":[],"created_at":"2026-04-10 11:47:40"},{"id":104,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-10-gba-pd","gap_id":"gba-pd","question":"GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-10 11:03:12"},{"id":103,"event_type":"debate_round_completed","source":"scidex_orchestrator","payload":{"session_id":"sess_SDA-2026-04-08-gap-debate-20260406-062045-ce866189","analysis_id":"SDA-2026-04-08-gap-debate-20260406-062045-ce866189","question":"The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite their cardiovascular success and shared inflammatory pathways. This paradox suggests unknown mechanistic differences that ","num_rounds":4,"quality_score":0.5,"num_hypotheses_generated":7,"num_hypotheses_surviving":6},"consumed_by":["market_dynamics"],"created_at":"2026-04-10 03:47:01"},{"id":102,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-debate-20260406-062045-ce866189","gap_id":"SDA-2026-04-08-gap-debate-20260406-062045-ce866189","question":"The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite their cardiovascular success and shared inflammatory pathways. This paradox suggests unknown mechanistic differences that could inform therapeutic design.\n\nSource: Debate session sess_SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404 (Analysis: SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404)","domain":"clinical neurology"},"consumed_by":[],"created_at":"2026-04-10 03:44:54"},{"id":101,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-debate-20260406-062045-ce866189","gap_id":"SDA-2026-04-08-gap-debate-20260406-062045-ce866189","question":"The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite their cardiovascular success and shared inflammatory pathways. This paradox suggests unknown mechanistic differences that could inform therapeutic design.\n\nSource: Debate session sess_SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404 (Analysis: SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404)","domain":"clinical neurology"},"consumed_by":[],"created_at":"2026-04-09 21:53:53"},{"id":100,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd","gap_id":"SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd","question":"The debate identified fundamental druggability challenges for these targets due to their essential roles, but specific molecular approaches to achieve selectivity for tau-containing vesicles versus normal cellular functions were not resolved. Novel targeting strategies are needed.\n\nSource: Debate session sess_SDA-2026-04-04-gap-tau-prop-20260402003221 (Analysis: SDA-2026-04-04-gap-tau-prop-20260402003221)","domain":"molecular biology"},"consumed_by":[],"created_at":"2026-04-09 21:51:32"},{"id":99,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-debate-20260406-062101-7751c220","gap_id":"SDA-2026-04-08-gap-debate-20260406-062101-7751c220","question":"The highest-ranked hypothesis assumes senescence reversibility through metabolic reprogramming, but the debate did not establish whether senescent cells can return to normal function or only halt further deterioration. This mechanistic distinction is fundamental to therapeutic expectations.\n\nSource: Debate session sess_SDA-2026-04-04-gap-senescent-clearance-neuro (Analysis: SDA-2026-04-04-gap-senescent-clearance-neuro)","domain":"cell biology"},"consumed_by":[],"created_at":"2026-04-09 21:48:45"},{"id":98,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8","question":"The authors identify SPI1 as a potential transcription factor regulating the hub genes but provide no mechanistic details of this regulatory relationship. Given SPI1's role in microglial activation and neuroinflammation, this regulatory circuit may be relevant to cerebrovascular disease and neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)","domain":"neuroinflammation"},"consumed_by":[],"created_at":"2026-04-09 21:46:08"},{"id":97,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062128-34a47c4e","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062128-34a47c4e","question":"The study reports that complement-mediated synaptic elimination produces both cognitive deficits and anxiety-like behaviors, but doesn't explain how the same hippocampal synaptic loss generates these distinct behavioral phenotypes. This mechanistic gap limits understanding of perioperative neurocognitive disorders.\n\nGap type: unexplained_observation\nSource paper: Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. (2023, BMC Med, PMID:36600274)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-09 21:42:49"},{"id":96,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062207-5a703c17","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062207-5a703c17","question":"While the abstract establishes that intercellular transmission occurs for various proteins (tau, α-synuclein, TDP-43), the mechanisms governing transmission selectivity and efficiency remain poorly understood. This gap impedes development of transmission-blocking therapeutics.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-09 21:40:11"},{"id":95,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062218-580b17ef","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062218-580b17ef","question":"The study identifies ADCY8 as associated with migratory distance differences and suggests long-term memory as the selective agent, but the specific molecular mechanisms linking ADCY8 to memory-based navigation remain unexplained. Understanding this pathway could reveal fundamental principles of memory encoding for spatial navigation.\n\nGap type: unexplained_observation\nSource paper: Climate-driven flyway changes and memory-based long-distance migration. (2021, Nature, PMID:33658718)","domain":"memory and navigation"},"consumed_by":[],"created_at":"2026-04-09 21:37:41"},{"id":94,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755","gap_id":"SDA-2026-04-08-gap-debate-20260406-062033-fecb8755","question":"While APOE4 disrupts microglial metabolism broadly, the debate didn't identify which specific disrupted pathways offer the best therapeutic targets. This prioritization is needed for focused drug development efforts.\n\nSource: Debate session sess_SDA-2026-04-04-gap-neuroinflammation-microglial-20260404 (Analysis: SDA-2026-04-04-gap-neuroinflammation-microglial-20260404)","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-09 21:34:21"},{"id":93,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9","question":"The abstract notes that clinical presentations overlap across different myelopathy etiologies, but the mechanistic basis for this convergent phenotype is not explained. Resolving this could improve differential diagnosis and reveal common therapeutic targets.\n\nGap type: unexplained_observation\nSource paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)","domain":"neuroinflammation"},"consumed_by":[],"created_at":"2026-04-09 21:31:30"},{"id":92,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-SDA-2026-04-08-gap-pubmed-20260406-062218-5c7f15f4","gap_id":"SDA-2026-04-08-gap-pubmed-20260406-062218-5c7f15f4","question":"The paper describes memory-based migration routes maintained across generations but doesn't explain the neural substrate for this long-term spatial memory storage and transmission. This represents a major gap in understanding how complex spatial memories persist across evolutionary timescales.\n\nGap type: unexplained_observation\nSource paper: Climate-driven flyway changes and memory-based long-distance migration. (2021, Nature, PMID:33658718)","domain":"spatial memory"},"consumed_by":[],"created_at":"2026-04-09 21:29:00"},{"id":91,"event_type":"analysis_started","source":"scidex_orchestrator","payload":{"analysis_id":"SDA-2026-04-09-gba-pd","gap_id":"gba-pd","question":"GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease","domain":"neurodegeneration"},"consumed_by":[],"created_at":"2026-04-09 21:12:11"}],"stats":{"total_events":190,"recent_24h":3,"by_type":{"analysis_completed":2,"analysis_started":163,"debate_round_completed":24,"hypothesis_scored":1}},"count":100}